论文部分内容阅读
目的:研究思密达联合利多卡因治疗手足口病所致口腔溃疡的临床疗效及患儿接受度。方法:将76例手足口病致口腔溃疡患儿随机地分为治疗组与对照组,各38例,比较两组临床疗效及患儿接受度。结果:治疗组总有效率为94.74%,对照组总有效率为63.16%。两组临床疗效差异明显(P<0.05),治疗组疗效明显优于对照组;同时治疗组患儿治疗的配合度,明显优于对照组(P<0.05)。结论:采用思密达联合利多卡因治疗手足口病所致口腔溃疡可以显著提高临床疗效及患儿接受度。
Objective: To study the clinical efficacy and the degree of acceptability of Smecta combined with lidocaine in the treatment of oral ulcer caused by hand-foot-mouth disease. Methods: A total of 76 children with oral ulcer caused by hand-foot-mouth disease were randomly divided into treatment group and control group, with 38 cases in each group. The clinical efficacy and children’s acceptance were compared between the two groups. Results: The total effective rate was 94.74% in the treatment group and 63.16% in the control group. The clinical curative effect of the two groups was significantly different (P <0.05), and the curative effect of the treatment group was obviously better than that of the control group. The therapeutic effect of the treatment group was obviously better than that of the control group (P <0.05). Conclusion: Smecta combined with lidocaine in the treatment of hand-foot-mouth disease caused by oral ulcer can significantly improve the clinical efficacy and child acceptance.